UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

CURRENT REPORT

 


 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 


 

Date of Report (Date of earliest event reported): April 5, 2006

 

(VISUALMED SOLUTIONS LOGO)

 

VISUALMED CLINICAL SOLUTIONS CORP.

(Exact name of registrant as specified in its charter)


 

 

 

 

 

Nevada

 

000-33191

 

88-0436055

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer Identification No.)


 

 

 

1035 Laurier St. West, Suite 200, Montreal, Quebec, Canada
(Address of principal executive offices)

 

H2V 2L1
(Zip Code)


 

(514) 274-1115

(Registrant’s telephone number, including area code)

 


(Former name or former address, if changed since last report)

          Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 7.01 Regulation FD Disclosure

VisualMED Clinical Solutions Corp. (OTC BB: VMCS) will be providing an expanded and comprehensive clinical information system to the Metropolitan Medical Center (MMC), a private Canadian hospital being built in Montreal.

VisualMED will be providing technology, as well as planning services, to the management corporation of the MMC.

The MMC will be the largest private surgery facility in eastern Canada.

The project is worth approximately $9 million over 5 years to the Company.

Item 9.01 Financial Statements and Exhibits

Exhibits.

99.1 - Press Release of VisualMED Clinical Solutions Corp., dated April 5, 2005

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated this 5th day of April, 2006.

VisualMED Clinical Solutions Corp.

 

 

By:

/s/ Barry Scharf

 

 

 

Barry Scharf, Chief of Operations

3


Exhibit Index

Exhibit No.      Description

     99.1       -    Press Release of VisualMED Clinical Solutions Corp., dated April 5, 2006.

4